Search Tag: personalised medicine

2016 18 May

The term Personalised Medicine has been extensively used within the last years to describe a paradigm shift in  research and medical application  towards an evidence based medicine. The Tübingen congress will focus on the clinical applicability of PM. Specifically we will highlight aquisition and analysis of highly complex data from patients, the...Read more

2015 25 Aug

In his State of the Union Address this January, President Obama announced the Precision Medicine Initiative (PMI) that was launched with a $215 million investment. PMI aims to enable a new era of medicine through research, technology, and policies that will lead to the development of individualised, tailored treatments for patients. PMI is looking...Read more

2015 25 Jun

The philosophy behind personalised medicine (also known as precision medicine) is that medical care and public health should be transformed by prevention and treatment programs that are specifically targeted to individual patients. Theoretically, this is to be achieved by sequencing more genomes, creating bigger biobanks, and linking biological information...Read more

2015 31 Mar

Is personalised medicine the future for critical care? Hector R. Wong (Cincinnati, USA), speaking at the 35th International Symposium on Critical Care and Emergency Medicine in Brussels last month, suggested it is, given that intensivists generally manage heterogeneous syndromes, such as ARDS, AKI and sepsis, rather than  distinct diseases. In critical...Read more

2015 30 Jan

Twelve years have passed since the mapping of the human genome in 2003. Since then, much has been learned about how people differ genetically. We may be 99.9 percent the same from a genetic perspective, but that differing 0.1 percent of genes comprises approximately three million genomic variants that are different between two people. Identifying the...Read more

2015 16 Jan

New research from Montreal Heart Institute (MHI) has found that cardiovascular patients with a specific genetic profile benefit greatly from the new medication dalcetrapib. The drug reduced heart attacks, strokes, unstable angina, coronary revascularisations and cardiovascular deaths by as much as 39 percent. The findings could pave the way for a new...Read more

2014 02 Jun

The steady growth of the next-generation sequencing (NGS) market in Western Europe is expected to continue thanks to a variety of new applications, from comprehensive oncology panels to non-invasive prenatal analysis to food testing. Major market potential exists in areas such as pre-implantation genetic diagnosis, infectious disease and companion diagnostics,...Read more

2013 17 Dec

Siemens Healthcare Diagnostics Inc. announced that it has entered into a master collaboration agreement with Pfizer Inc. to design, develop and commercialise diagnostic tests for therapeutic products across Pfizer’s pipeline. Under the agreement, Siemens will be one of Pfizer’s collaboration partners to develop and provide in vitro diagnostic tests...Read more